Page last updated: 2024-11-01

ns 1619 and Pulmonary Arterial Remodeling

ns 1619 has been researched along with Pulmonary Arterial Remodeling in 1 studies

NS 1619: structure given in first source
NS 1619 : A member of the class of benzimidazoles that is 1,3-dihydro-2H-benzimidazol-2-one in which the hydrogens at positions 1 and 5 are replaced are replaced by 2-hydroxy-5-(trifluoromethyl)phenyl and trifluoromethyl groups, respectively. It is an opener/activator of the large-conductance calcium-activated potassium channel (Bkca).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Wang, M1
Yin, X1
Li, S1
Zhang, X1
Yi, M1
He, C1
Li, X1
Wang, W1
Zhang, S1
Liu, H1

Other Studies

1 other study available for ns 1619 and Pulmonary Arterial Remodeling

ArticleYear
Large-Conductance Calcium-Activated Potassium Channel Opener, NS1619, Protects Against Mesenteric Artery Remodeling Induced by Agonistic Autoantibodies Against the Angiotensin II Type 1 Receptor.
    Journal of the American Heart Association, 2022, 02-15, Volume: 11, Issue:4

    Topics: Animals; Autoantibodies; Benzimidazoles; Calcium; Calcium, Dietary; HEK293 Cells; Humans; Large-Cond

2022